Email Phishing Incident: Learn More

About Us

NYOH News

  • Help us win $10,000!

    11/14/2019

    We need your vote! November 14th through December 5th, you can help NYOH Community Cancer Foundation win a $10,000 advertising package from the Times Union by casting your vote for us at: www.timesunion.com/capitalregiongives We are one of 38 charities competing -- and you can vote every day! Help us continue to assist local cancer patients and their... Read More

  • Heredity & Breast Cancer: Dr. Tedesco to speak at FREE Amsterdam Event

    10/31/2019

    Dr. Karen Tedesco will be answering questions about heredity and breast cancer at a FREE program hosted by Centro Civico on Tuesday, November 5, 2019 from 6:30pm – 7:30pm. Dr. Tedesco, a medical oncologist and hematologist, sees patients at NYOH’s Amsterdam office. She also serves as program director for NYOH’s Hereditary Risk Assessment Program and as... Read More

  • Dr. De Jesus Goes to Washington

    10/24/2019

    Arsyl De Jesus, MD, radiation oncologist at New York Oncology Hematology's Amsterdam office, recently spent the day in Washington, DC. Dr. De Jesus was on Capitol Hill to educate members of Congress, including Hon. Paul Tonko, about radiation therapy and advocate for ways to improve patient quality of care, lower costs, and maintain the viability of freestanding radiation therapy... Read More

  • Dr. Theodoulou discusses PARP Inhibitors for breast cancer

    10/18/2019

    NYOH's Dr. Maria Theodoulou and her patient, Andrea Burch, a breast cancer survivor, recently sat down with NewsChannel 13's Benita Zahn to share Andrea's story and how PARP inhibitors are being used to treat certain types of breast cancer.   A patient at our Hudson office, Andrea began seeing Dr. Theodoulou when she discovered her... Read More

  • Pat Brady, PA discusses Survivorship with Benita Zahn

    10/17/2019

    With earlier detection and improved treatment, more people today are living with cancer. As of January 2019, it is estimated that there are 16.9 million cancer survivors in the United States. This represents 5.0% of the population. That number is projected to grow to 26.1 million by 2040. NYOH’s Pat Brady, PA recently discussed the increasingly important role of survivorship... Read More

  • Dr. Negandhi answers breast cancer questions on Medical Monday

    10/08/2019

    NYOH's Ami Negandhi, MD was a recent guest on WAMC's Medical Monday call-in radio program. Dr. Negandhi, who specializes in breast cancer,  spent an hour taking listener's calls about exciting new treatments and clinical trials now available, as well as screenings and survivorship.  Listen to the full program Read More

  • Dr. DeJesus Speaks at Komen More than Pink Luncheon

    10/08/2019

    Arsyl De Jesus, MD, radiation oncologist at NYOH, was invited as keynote speaker at the Susan G. Komen Northeastern NY 25th Anniversary More Than Pink Luncheon, held recently at the Rivers Casino Event Center in Schenectady. Spectrum News Anchor JoDee Kenney emceed the sold out event of more than 250 people. Joining Dr. De Jesus was NYOH's ... Read More

  • Dr. Arsyl De Jesus featured speaker for the Susan G. Komen 25th Anniversary “More Than Pink” Luncheon

    10/02/2019

    The "More Than Pink" luncheon will honor Breast Cancer Survivors at the Rivers Casino, Schenectady on Sunday, October 6, 2019, 11:30 - 2:30. Read More

  • Dr. Wrzesinski discusses lung cancer, BreatheDeep on NewsChannel 13

    9/09/2019

    Dr. Stephen Wrzesinski discusses advances in lung cancer treatment as a guest on NewsChannel 13's HealthBeat program with Benita Zahn.  He joins Jennifer Barnhart, spouse of an NYOH patient and founder of the Breathe Deep/Lungevity Albany event, a 5K walk/run to raise money for lung cancer research. The event is being held Sunday, September 22nd at... Read More

  • Dr. Tedesco discusses first immunotherapy regimen for breast cancer

    9/03/2019

    Karen Tedesco, MD, was recently featured on the American Society of Clinical Oncology's national "Daily News" podcast.  She discusses the advancement in breast cancer treatment that came earlier this year, when the FDA granted accelerated approval to atezolizumab, the first cancer immunotherapy regimen for breast cancer. In addition to treating patients, Karen Tedesco, MD,... Read More

  • Next Page